Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatment.
Saved in:
| Title: | Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatment. |
|---|---|
| Authors: | Biava PM; Foundation for Research into the Biological Therapies on Cancer, IRCCS Multimedica, Milan, Italy. biava@tiscali.it, Basevi M, Biggiero L, Borgonovo A, Borgonovo E, Burigana F |
| Source: | Current pharmaceutical biotechnology [Curr Pharm Biotechnol] 2011 Feb 01; Vol. 12 (2), pp. 231-42. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 100960530 Publication Model: Print Cited Medium: Internet ISSN: 1873-4316 (Electronic) Linking ISSN: 13892010 NLM ISO Abbreviation: Curr Pharm Biotechnol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 21044002 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Biava+PM%22">Biava PM</searchLink>; Foundation for Research into the Biological Therapies on Cancer, IRCCS Multimedica, Milan, Italy. biava@tiscali.it<br /><searchLink fieldCode="AU" term="%22Basevi+M%22">Basevi M</searchLink><br /><searchLink fieldCode="AU" term="%22Biggiero+L%22">Biggiero L</searchLink><br /><searchLink fieldCode="AU" term="%22Borgonovo+A%22">Borgonovo A</searchLink><br /><searchLink fieldCode="AU" term="%22Borgonovo+E%22">Borgonovo E</searchLink><br /><searchLink fieldCode="AU" term="%22Burigana+F%22">Burigana F</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100960530%22">Current pharmaceutical biotechnology</searchLink> [Curr Pharm Biotechnol] 2011 Feb 01; Vol. 12 (2), pp. 231-42. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Bentham+Science+Publishers%22">Bentham Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>100960530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4316 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213892010%22">13892010 </searchLink><i>NLM ISO Abbreviation: </i>Curr Pharm Biotechnol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21044002 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2174/138920111794295783 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 231 Titles: – TitleFull: Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Biava PM – PersonEntity: Name: NameFull: Basevi M – PersonEntity: Name: NameFull: Biggiero L – PersonEntity: Name: NameFull: Borgonovo A – PersonEntity: Name: NameFull: Borgonovo E – PersonEntity: Name: NameFull: Burigana F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2011 Feb 01 Type: published Y: 2011 Identifiers: – Type: issn-electronic Value: 1873-4316 Numbering: – Type: volume Value: 12 – Type: issue Value: 2 Titles: – TitleFull: Current pharmaceutical biotechnology Type: main |
| ResultId | 1 |